Bis(palladium(2+));tetrakis(propan-2-yl-[(Z)-4-propan-2-yliminopent-2-en-2-yl]azanide)
C44H84N8Pd2 — CID 139104906
Data last refreshed: (MolForge compound catalog, from PubChem)
About Bis(palladium(2+));tetrakis(propan-2-yl-[(Z)-4-propan-2-yliminopent-2-en-2-yl]azanide)
Bis(palladium(2+));tetrakis(propan-2-yl-[(Z)-4-propan-2-yliminopent-2-en-2-yl]azanide) (PubChem CID 139104906) has the molecular formula C44H84N8Pd2 and a molecular weight of 938.05 g/mol. Its IUPAC name is bis(palladium(2+));tetrakis(propan-2-yl-[(Z)-4-propan-2-yliminopent-2-en-2-yl]azanide).
Molecular Properties
| Compound Name | Bis(palladium(2+));tetrakis(propan-2-yl-[(Z)-4-propan-2-yliminopent-2-en-2-yl]azanide) |
|---|---|
| PubChem CID | 139104906 |
| Molecular Formula | C44H84N8Pd2 |
| Molecular Weight | 938.05 g/mol |
| Exact Mass | 936.49 |
| IUPAC Name | bis(palladium(2+));tetrakis(propan-2-yl-[(Z)-4-propan-2-yliminopent-2-en-2-yl]azanide) |
| SMILES | C/C(=C/C(C)=N/C(C)C)[N-]C(C)C.C/C(=C/C(C)=N/C(C)C)[N-]C(C)C.C/C(=C/C(C)=N/C(C)C)[N-]C(C)C.C/C(=C/C(C)=N/C(C)C)[N-]C(C)C.[Pd+2].[Pd+2] |
| InChI | InChI=1S/4C11H21N2.2Pd/c4*1-8(2)12-10(5)7-11(6)13-9(3)4;;/h4*7-9H,1-6H3;;/q4*-1;2*+2/b4*10-7-,13-11+;; |
| InChIKey | VLJYIEJBWCWMMD-SLYAMHCJSA-N |
| XLogP | 14.16 |
| TPSA | 105.84 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 16 |
| Heavy Atoms | 54 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 938.05 |
| LogP ≤ 5 | 14.16 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 4 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'imine_1', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 139104906 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.